ClinicalTrials.govpublic full text
Pembrolizumab Plus Lenvatinib in Unresectable Cutaneous Angiosarcoma Patients
angiosarcoma of skin, angiosarcoma metastatic, pembrolizumab, lenvatinib, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 981850
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.